SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 276.4 CNY | -1.31% |
|
-4.54% | +51.58% |
| May. 15 | Shenyang Xingqi Pharmaceutical Co.,Ltd. Announces Cash Dividend for 2023, Payable May 22, 2024 | CI |
| Apr. 26 | Shenyang Xingqi Pharmaceutical's Q1 Profit Jumps 80% | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.12B 293M | Sales 2025 * | 2.68B 371M | Capitalization | 34.43B 4.77B |
|---|---|---|---|---|---|
| Net income 2024 * | 449M 62.16M | Net income 2025 * | 669M 92.62M | EV / Sales 2024 * | 16.3 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 12.8 x |
| P/E ratio 2024 * |
76.8
x | P/E ratio 2025 * |
51.5
x | Employees | 1,995 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.96% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.31% | ||
| 1 week | -4.54% | ||
| Current month | +6.46% | ||
| 1 month | +27.94% | ||
| 3 months | +73.31% | ||
| 6 months | +82.54% | ||
| Current year | +51.58% |
1 week
269.70
299.99
1 month
207.67299.99
Current year
130.00299.99
1 year
112.24299.99
3 years
56.07299.99
5 years
33.26299.99
10 years
4.42299.99
| Managers | Title | Age | Since |
|---|---|---|---|
E Gao
CEO | Chief Executive Officer | 50 | 00-07-04 |
| 37 | - | ||
Ya Nan Cheng
DFI | Director of Finance/CFO | 50 | 02-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiao Yan Kong
BRD | Director/Board Member | 51 | Jan. 04 |
Ji Dong Liu
CHM | Chairman | 67 | 00-07-04 |
E Gao
CEO | Chief Executive Officer | 50 | 00-07-04 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 12 M€ | -16.71% | - | |
| 0.00% | 34 M€ | +3.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 276.4 | -1.31% | 3,223,274 |
| 24-05-16 | 280 | -0.49% | 1,883,505 |
| 24-05-15 | 281.4 | -3.62% | 3,001,588 |
| 24-05-14 | 292 | +0.34% | 1,809,036 |
| 24-05-13 | 291 | +0.51% | 3,467,300 |
End-of-day quote Shenzhen S.E., May 16, 2024
More quotes
SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
276.4
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +51.58% | 4.77B | |
| +10.23% | 8.96B | |
| -10.76% | 5.19B | |
| +12.50% | 4.26B | |
| -20.70% | 2.37B | |
| +12.83% | 2.3B | |
| -29.65% | 2.21B | |
| +19.51% | 2.17B | |
| -0.50% | 1.64B | |
| +0.55% | 1.6B |
- Stock Market
- Equities
- 300573 Stock
